123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.

Booij, J.
Speelman, J.D.
Horstink, M.W.I.M.
Wolters, E.C.

January 2001

[123I]FP-CIT (N-omega-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane) has been dev...

[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes

Hauser, Robert A.
Grosset, Donald G.

July 2012

Objective: To review [ 123I]FP-CIT (Ioflupane I 123, DaTscan) SPECT imaging and its role in clinical...

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort.

Nicastro, Nicolas
Garibotto, Valentina
Burkhard, Pierre R

May 2021

BACKGROUND: Neuropathological data and nuclear medicine imaging show extensive serotonergic impairme...

123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

Filippi, L
Manni, C
Pierantozzi, M
Brusa, L
Danieli, R
Stanzione, P
Schillaci, O

May 2005

123I-FP-CIT SPECT has been successfully used to detect the loss of dopaminergic nigrostriatal neuron...

The value of semi-quantitative analysis of 123I-FP-CIT SPECT in evaluating patients with parkinson's disease

Filippi,L
Bruni,C
Padovano,F
SCHILLACI, ORAZIO
SIMONETTI, GIOVANNI MARIA EGISTO

January 2008

123I-FP-CIT SPECT binding to striatal dopamine transporter (DAT) is markedly reduced in patients wit...

The role of [123I]-FP-CIT SPECT in the diagnosis and clinical management of Parkinson’s Disease.

L. M. Feggi
S. Panareo
C. Sensi
S. Fabbri
M. Casali
E. Fainardi
N. Prandini
E. Bagatin
A. Costanzo
S. Mangherini
F. Preda
R. Quatrale
CITTANTI, Corrado
GIGANTI, Melchiore

January 2006

The diagnosis of Parkinson’s Disease (PD) is based on clinical features with imaging confirmation. ...

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease

Booij, J.
Habraken, J. B.
Bergmans, P.
Tissingh, G.
Winogrodzka, A.
Wolters, E. C.
Janssen, A. G.
Stoof, J. C.
van Royen, E. A.

January 1998

Several SPECT studies reported decreased striatal 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta...

Clinical Applications of [123I]FP-CIT SPECT Imaging

Booij, Jan
de Koning-Tijssen, Marina. A. J.
Berendse, Henk W.

April 2014

Dopamine transporter (DAT) imaging with [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nort...

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.

Catafau, Ana M
Tolosa, Eduardo
Vander Borght, Thierry
Laloux, Patrice

January 2004

Imaging with (123)I-Ioflupane single-photon emission computed tomography (SPECT) is a marker of nigr...

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort

Nicastro, Nicolas
Garibotto, Valentina
Burkhard, Pierre

January 2020

Neuropathological data and nuclear medicine imaging show extensive serotonergic impairment in Parkin...

Analysis of extrastriatal 123I-FP-CIT binding contributes to the differential diagnosis of parkinsonian diseases

Joling, Merijn
Vriend, Chris
Van Den Heuvel, Odile A.
Raijmakers, Pieter G.H.M.
Jones, Paul A.
Berendse, Henk W.
Booij, Jan

July 2017

123I-N-v-fluoropropyl-2b-carbomethoxy-3b-(4-iodophenyl)nortropane (123I-FP-CIT) SPECT can visualize ...

Extrastriatal 123I-FP-CIT SPECT impairment in degenerative parkinsonisms

Nicastro, Nicolas
Fleury, Vanessa
Broc, Nicolas
Burkhard, Pierre
Garibotto, Valentina

January 2020

Introduction:Neuropathological data and nuclear medicine imaging show extensive serotonergic impairm...

Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)

Nicastro, Nicolas
Burkhard, Pierre
Garibotto, Valentina

January 2020

Scans without evidence of dopaminergic deficit (SWEDD) have been initially described in a minority o...

Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy.

El Fakhri, Georges
Habert, Marie-Odile
Maksud, Philippe
Kas, Aurélie
Malek, Zoulikha
Kijewski, Marie Foley
Lacomblez, Lucette

January 2006

PURPOSE: The purpose of this study was to investigate the feasibility and utility of dual-isotope SP...

Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.

COVELLI EM
A. BRUNETTI
DI LAURO A
SULLO P
MAZZARELLA G
TEDESCHI E
BELFIORE G

January 2004

Here we report our experience in a general hospital setting using [(123)I]-FP-CIT SPECT to diagnose ...

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.

Booij, J.
Speelman, J.D.
Horstink, M.W.I.M.
Wolters, E.C.

January 2001

[123I]FP-CIT (N-omega-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane) has been dev...

[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes

Hauser, Robert A.
Grosset, Donald G.

July 2012

Objective: To review [ 123I]FP-CIT (Ioflupane I 123, DaTscan) SPECT imaging and its role in clinical...

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort.

Nicastro, Nicolas
Garibotto, Valentina
Burkhard, Pierre R

May 2021

BACKGROUND: Neuropathological data and nuclear medicine imaging show extensive serotonergic impairme...

123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

Filippi, L
Manni, C
Pierantozzi, M
Brusa, L
Danieli, R
Stanzione, P
Schillaci, O

May 2005

123I-FP-CIT SPECT has been successfully used to detect the loss of dopaminergic nigrostriatal neuron...

The value of semi-quantitative analysis of 123I-FP-CIT SPECT in evaluating patients with parkinson's disease

Filippi,L
Bruni,C
Padovano,F
SCHILLACI, ORAZIO
SIMONETTI, GIOVANNI MARIA EGISTO

January 2008

123I-FP-CIT SPECT binding to striatal dopamine transporter (DAT) is markedly reduced in patients wit...

The role of [123I]-FP-CIT SPECT in the diagnosis and clinical management of Parkinson’s Disease.

L. M. Feggi
S. Panareo
C. Sensi
S. Fabbri
M. Casali
E. Fainardi
N. Prandini
E. Bagatin
A. Costanzo
S. Mangherini
F. Preda
R. Quatrale
CITTANTI, Corrado
GIGANTI, Melchiore

January 2006

The diagnosis of Parkinson’s Disease (PD) is based on clinical features with imaging confirmation. ...

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease

Booij, J.
Habraken, J. B.
Bergmans, P.
Tissingh, G.
Winogrodzka, A.
Wolters, E. C.
Janssen, A. G.
Stoof, J. C.
van Royen, E. A.

January 1998

Several SPECT studies reported decreased striatal 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta...

Clinical Applications of [123I]FP-CIT SPECT Imaging

Booij, Jan
de Koning-Tijssen, Marina. A. J.
Berendse, Henk W.

April 2014

Dopamine transporter (DAT) imaging with [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nort...

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.

Catafau, Ana M
Tolosa, Eduardo
Vander Borght, Thierry
Laloux, Patrice

January 2004

Imaging with (123)I-Ioflupane single-photon emission computed tomography (SPECT) is a marker of nigr...

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort

Nicastro, Nicolas
Garibotto, Valentina
Burkhard, Pierre

January 2020

Neuropathological data and nuclear medicine imaging show extensive serotonergic impairment in Parkin...

Analysis of extrastriatal 123I-FP-CIT binding contributes to the differential diagnosis of parkinsonian diseases

Joling, Merijn
Vriend, Chris
Van Den Heuvel, Odile A.
Raijmakers, Pieter G.H.M.
Jones, Paul A.
Berendse, Henk W.
Booij, Jan

July 2017

123I-N-v-fluoropropyl-2b-carbomethoxy-3b-(4-iodophenyl)nortropane (123I-FP-CIT) SPECT can visualize ...

Extrastriatal 123I-FP-CIT SPECT impairment in degenerative parkinsonisms

Nicastro, Nicolas
Fleury, Vanessa
Broc, Nicolas
Burkhard, Pierre
Garibotto, Valentina

January 2020

Introduction:Neuropathological data and nuclear medicine imaging show extensive serotonergic impairm...

Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)

Nicastro, Nicolas
Burkhard, Pierre
Garibotto, Valentina

January 2020

Scans without evidence of dopaminergic deficit (SWEDD) have been initially described in a minority o...

Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy.

El Fakhri, Georges
Habert, Marie-Odile
Maksud, Philippe
Kas, Aurélie
Malek, Zoulikha
Kijewski, Marie Foley
Lacomblez, Lucette

January 2006

PURPOSE: The purpose of this study was to investigate the feasibility and utility of dual-isotope SP...

Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.

COVELLI EM
A. BRUNETTI
DI LAURO A
SULLO P
MAZZARELLA G
TEDESCHI E
BELFIORE G

January 2004

Here we report our experience in a general hospital setting using [(123)I]-FP-CIT SPECT to diagnose ...

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.

Booij, J.
Speelman, J.D.
Horstink, M.W.I.M.
Wolters, E.C.

January 2001

[123I]FP-CIT (N-omega-fluoropropyl-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane) has been dev...

[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes

Hauser, Robert A.
Grosset, Donald G.

July 2012

Objective: To review [ 123I]FP-CIT (Ioflupane I 123, DaTscan) SPECT imaging and its role in clinical...

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort.

Nicastro, Nicolas
Garibotto, Valentina
Burkhard, Pierre R

May 2021

BACKGROUND: Neuropathological data and nuclear medicine imaging show extensive serotonergic impairme...

123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

Abstract

Extracted data

123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

Abstract

Extracted data

Related items

Related items